Peptide ChooserPeptides and their FDA status
Every peptide and approved alternative we track, 41 in all, with its FDA status, its source and the lowest price we show. Each name opens its page; we do not link to shops or clinics.
Checked 2 Nov 2026Lowest price: per mg at the shops we show, or per month at the online clinics for an approved medicine.
FDA approved
11 substances. Approved medicines: an FDA-approved product exists for a stated use.
| Substance | Status | What that means | Lowest price |
|---|---|---|---|
| Afamelanotide | FDA approved | an FDA-approved product exists | none shown |
| Bremelanotide | FDA approved | an FDA-approved product exists | none shown |
| Elamipretide | FDA approved | an FDA-approved product exists | none shown |
| Finasteride | FDA approved | an FDA-approved product exists | $25/mo |
| Liraglutide | FDA approved | an FDA-approved product exists | none shown |
| Minoxidil | FDA approved | an FDA-approved product exists | $30/mo |
| Oxytocin | FDA approved | an FDA-approved product exists | none shown |
| Semaglutide | FDA approved | an FDA-approved product exists | $149/mo |
| Somatropin | FDA approved | an FDA-approved product exists | none shown |
| Tesamorelin | FDA approved | an FDA-approved product exists | none shown |
| Tirzepatide | FDA approved | an FDA-approved product exists | $299/mo |
Not approved
28 substances. No approved product; research-use shops sell most of them, and some may be made by pharmacies.
| Substance | Status | What that means | Lowest price |
|---|---|---|---|
| AOD-9604 | Not approved | its nomination for pharmacy compounding was withdrawn | none shown |
| ARA-290 | Not approved | nominated for compounding without enough data; pharmacies may not compound it | none shown |
| BPC-157 | Not approved | its nomination for pharmacy compounding was withdrawn | $1.14/mg |
| CJC-1295 | Not approved | its nomination for pharmacy compounding was withdrawn | $0.099/mg |
| Delta sleep-inducing peptide | Not approved | its nomination for pharmacy compounding was withdrawn | none shown |
| Dihexa | Not approved | its nomination for pharmacy compounding was withdrawn | none shown |
| Epitalon | Not approved | its nomination for pharmacy compounding was withdrawn | $0.42/mg |
| GHK-Cu | Not approved | its nomination for pharmacy compounding was withdrawn | $0.028/mg |
| GHRP-2 | Not approved | on the FDA list of substances that may be unsafe to compound | none shown |
| GHRP-6 | Not approved | on the FDA list of substances that may be unsafe to compound | none shown |
| Glutathione | Pharmacy-made | pharmacies may compound it while the FDA reviews it; no approved product | none shown |
| Ibutamoren | Not approved | on the FDA list of substances that may be unsafe to compound | none shown |
| Ipamorelin | Not approved | on the FDA list of substances that may be unsafe to compound | $1.14/mg |
| Kisspeptin-10 | Not approved | on the FDA list of substances that may be unsafe to compound | none shown |
| KPV | Not approved | its nomination for pharmacy compounding was withdrawn | none shown |
| LL-37 | Not approved | its nomination for pharmacy compounding was withdrawn | none shown |
| Mechano growth factor | Not approved | nominated for compounding without enough data; pharmacies may not compound it | none shown |
| Melanotan II | Not approved | its nomination for pharmacy compounding was withdrawn | $1.00/mg |
| MOTS-c | Not approved | its nomination for pharmacy compounding was withdrawn | $0.50/mg |
| NAD+ | Pharmacy-made | pharmacies may compound it while the FDA reviews it; no approved product | $0.023/mg |
| PEG-MGF | Not approved | its nomination for pharmacy compounding was withdrawn | none shown |
| Retatrutide | Not approved | in clinical trials; no approved product | $0.60/mg |
| Selank | Not approved | its nomination for pharmacy compounding was withdrawn | none shown |
| Semax | Not approved | its nomination for pharmacy compounding was withdrawn | none shown |
| TB-500 (thymosin beta-4 fragment 17-23) | Not approved | its nomination for pharmacy compounding was withdrawn | $1.28/mg |
| Thymosin alpha-1 | Not approved | its nomination for pharmacy compounding was withdrawn | none shown |
| Thymulin | Not approved | nominated for compounding without enough data; pharmacies may not compound it | none shown |
| Vasoactive intestinal peptide | Pharmacy-made | pharmacies may compound it while the FDA reviews it; no approved product | none shown |
Cosmetic
2 substances. Sold in creams and serums; cosmetics do not need FDA approval.
| Substance | Status | What that means | Lowest price |
|---|---|---|---|
| Acetyl hexapeptide-8 (Argireline) | Cosmetic | cosmetics are regulated but do not need FDA approval to be sold | $0.49/mg |
| Palmitoyl pentapeptide-4 (Matrixyl) | Cosmetic | cosmetics are regulated but do not need FDA approval to be sold | $0.14/mg |